FDA Approved: STEQEYMA — Supplemental Application (CELLTRION USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for STEQEYMA (ustekinumab-stba) from Celltrion USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• STEQEYMA (USTEKINUMAB-STBA)

Snippet

SUPPL AP for STEQEYMA (USTEKINUMAB-STBA)